Sonnet Biotherapeutics Holdings Inc (NASDAQ:SONN)

Delayed Data
As of 3:58pm ET
 +0.055 / +1.94%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Sonnet Biotherapeutics Holdings Inc have a median target of 75.00, with a high estimate of 100.00 and a low estimate of 44.00. The median estimate represents a +2,499.65% increase from the last price of 2.89.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Sonnet Biotherapeutics Holdings Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 90.73%
Growthannually 98.80%


Growthquarterly -100.00%
Growthannually -100.00%
Key to the earnings and sales forecast charts.